N	Concordance
1	uality of life effects of docetaxel and estramustine combination in  patients wi
2	The agents studied most extensively are estramustine phosphate, prednimustine, a
3	       the rate of efflux of dansylated estramustine was increased in SKEM compa
4	hase II trial utilizing a lower dose of estramustine (10 mg/kg/day) and allowing
5	on.  II. Determine the toxic effects of estramustine and etoposide in these  pat
6	tionally linked with enhanced efflux of estramustine in ovarian carcinoma 
7	ty of 96-hour paclitaxel and daily oral estramustine phosphate (EMP) in patients
8	hanges rapidly when they are exposed to estramustine phosphate (EMP). When the c
9	 - The drug transport properties of two estramustine-resistant DU145 human
10	line hormonal therapy were treated with estramustine and additionally randomized
11	          treatment of LNCaP cells with estramustine induced apoptosis, but no